Introduction 52
Hutchinson-Gilford Progeria Syndrome (HGPS) is an extremely rare ge-53 netic disorder. Children with HGPS present a high incidence of severe cardio-54 vascular complications along with altered metabolic processes, associated with 55 an accelerated aging process (1-4). Despite a great increase in the scientific 56 knowledge about HGPS, no specific biomarker is known for HGPS and the un-57 derlying molecular mechanisms are not fully understood. HGPS is induced by a 58 single mutation in the LMNA gene, creating a mutant protein isoform with dele-59 tion of 50 amino-acids near in the protein Lamin A. The mutated protein, known 60 as progerin (isoform 6), is toxically accumulated in the cells. Progerin, despite 61 being able to enter the cell nucleus, does not incorporate normally into the nu-62 clear membrane lamina, leading to several abnormalities in nuclear trafficking(5, 63 6). Interestingly, unaffected aged individuals show a similar splice event, lead-64 ing to progerin expression that may play a role in cellular senescence (6) . 65
Aging is the biological process of gradually accumulating deleterious 66 changes in cells, decreasing the physiological capacity (7, 8) . Aging is not con-67 sidered a disease, but it intensely rises the risk of developing chronic cardio-68 vascular(9) and metabolic diseases(10). It is known that metabolic systemic 69 profiles are age-dependent, reflecting metabolism alterations, such as incom-70 plete fatty acid mitochondrial oxidation(11-13). 71
Metabolomics is, among other "omics" strategies, one of the most com-72 plete and reliable sources of information for circulatory mediator analysis, bi-73 omarker discovery pipeline and mechanistic disease investigation (14) . In the 74 present study, we applied metabolomics to samples from HGPS patients and 75 identified several metabolites from different biological pathways dysregulated. 76
Multivariate and univariate statistical analysis demonstrated metabolic pathways 77 and potential new biomarkers that might act as central mediators in this syn-78 drome and in senescence. Metabolites were ranked according to their capacity to distinguish be-125 tween HGPS and Control subjects and the result is summarized in figure 2b . 126
Metabolites are shown as either downregulated (green) or upregulated (red) in 127 patients with HGPS. Furthermore, we performed classical univariate ROC curve 128 analysis for individual biomarkers. Aiming to evaluate the most relevant metabolic pathways altered in pa-143 tients with HGPS, pathway analysis was applied. Figure 5 shows an overview of 144 Pathway Analysis, using only annotated metabolites identified to be significantly 145 altered by HGPS. Figure 5a highlights pathways related to upregulated metabo-146 lites, suggesting alterations in fatty acids metabolism, glucose metabolism, and 147 mitochondrial function. Figure 5b shows . In the present work, we created ROC curve models to identify metabolic 160 HPGS biomarkers. As shown in results, biomarkers found to be statistically dif-161 ferent between the HGPS and control groups are highly likely to be associated 162 with premature aging based on performance in terms of both specificity and 163 sensitivity. Furthermore, targeted analysis using high purity standards of the 164 in accordance with our data using HGPS plasma, where we observed an in-178 crease in glucose and lactide, a dimer of lactic acid (Table 1) . Metabolomic 179 studies in diabetic patients also demonstrate glucose and lactate increase(21). 180
In addition to the glucose/pyruvate pathway alteration, we observed an increase 181 in a long chain carnitine family molecule, Acetyl-L-Carnitine, associated with 182 fatty oxidation. Interestingly, children in early-stage type 1 diabetes present ele-183 vated Acyl-Carnitine. Adult patients with type 2 diabetes may also present 184 dysregulation of fatty acid oxidation, characterized by glucolipotoxicity(22). In 185 this context, it is interesting to note that a recent study demonstrated that met-186 formin, a popular anti-diabetic biguanide, alleviates the nuclear defects and 187 premature aging phenotypes in HGPS fibroblasts, perhaps constituting a prom-188 ising therapeutic approach for life extension in HGPS(23). Furthermore, insulin 189 resistance has been described in children with HGPS(24). showed that methionine is decreased in the plasma of aged mice and no 215 changes were observed in BCAA(20). Interestingly, choline supplementation 216 seems to improve cognitive function and is an important strategy to ameliorates 217
Alzheimer's disease pathology, a pathological process typically associated with 218 advanced age(35, 36). Furthermore, choline converts homocysteine, a neuro-219 toxic amino acid in methionine(37, 38), also found to be decreased in the HGPS 220 patients in the present work. 221 222 Altered metabolic processes can lead to the formation of toxic metabo-223 lites as well as alterations in acid-base equilibrium. Interestingly, the 4,6-224 dioxoheptanoic acid, also known as Succinylacetone, a medium-chain keto ac-225 id, and derivative metabolite, was found in higher levels in HGPS plasma. possibility that the diverse genetic backgrounds might influence the metabolic 247 plasma levels, our approach based in the multivariate analysis of multiple me-248 tabolites was capable to clearly separate patients from controls, generating an 249 important biomarker profile related to the disease, even using a very small 250 sample size. 251
In summary, the present work applied a powerful metabolomics pipeline 252
Conclusions 259
The present study reports for the first time a metabolic profiling with LC-MS 260 
Non-targeted metabolomics 306
For liquid chromatography-tandem mass spectrometry (LC-MS) analysis, 307 5µl volumes of each sample were analyzed in triplicate. As a blank control, 308 methanol/water followed the same steps and was used as background for data 309 analysis as previously described(15). Between samples, a washing protocol 310 was performed. Samples were analyzed in a random sequence and the QC 311 sample was analyzed 5 different times along the experiment. 
